The basic principle in the Biocidal Products Regulation ((EU) No 528/2012 (BPR)) is that a biocidal product (BP) must be authorised before it can be made available on the market or used in the European Union (EU)/ European Economic Area (EEA).
This takes place in two consecutive steps. As the first step, the active substance is evaluated and, provided the criteria are fulfilled, is then approved in a specified product-type (PT). The second step is the authorisation of each BP consisting of, containing or generating the approved active substance(s).
This document concerns the first step, approval of active substances.
October 2016
Collegati
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 100D (2012)
***This book was highly commended in the Public Health category of the British Medica...
La presente guida è rivolta a tutte le imprese del settore manifatturiero, che utilizzano prodotti chimici nello svolgimento d...
ID 24282 | 15.07.2025 / In allegato
Relazione annuale del Direttore dell'ISIN al Governo e al Parlamento sulle attività svolte d...
Testata editoriale iscritta al n. 22/2024 del registro periodici della cancelleria del Tribunale di Perugia in data 19.11.2024
